BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33639914)

  • 41. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
    Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
    J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
    Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
    Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and prognostic impact of preoperative thrombocytosis in muscle invasive bladder cancer: Any role in clinical practice?
    Sretenovic M; Bojanic N; Grozdic Milojevic I; Bumbasirevic U; Radisavcevic D; Bulat P; Sipetic Grujicic S; Milojevic B
    J Clin Ultrasound; 2023; 51(9):1607-1614. PubMed ID: 37882791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
    Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
    BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
    Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study.
    Kim SH; Lee DE; Joung JY; Seo HK; Lee KH; Chung J
    Investig Clin Urol; 2020 Mar; 61(2):146-157. PubMed ID: 32158965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.
    Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE
    BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognostic factors for metastatic renal cell carcinoma treated with second-line targeted therapies].
    Rebibo JD; Pfister C; Giwerc A; Defortescu G; Gouerant S; Di Fiore F; Nouhaud FX
    Prog Urol; 2016 Jan; 26(1):16-23. PubMed ID: 26455779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience.
    Liu Z; Tang S; Tian X; Zhang H; Wang G; Zhang S; Ma L
    BMC Cancer; 2020 Jan; 20(1):61. PubMed ID: 31992244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus.
    Abel EJ; Wood CG; Eickstaedt N; Fang JE; Kenney P; Bagrodia A; Youssef RF; Sagalowsky AI; Margulis V
    J Urol; 2013 Aug; 190(2):452-7. PubMed ID: 23434945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus.
    Whitson JM; Reese AC; Meng MV
    Urol Oncol; 2013 Feb; 31(2):259-63. PubMed ID: 21795070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.
    Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.
    Kwon T; Lee JL; You D; Jeong IG; Song C; Ahn H; Kim CS; Hong JH
    J Surg Oncol; 2014 Aug; 110(2):145-50. PubMed ID: 24706355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.